Dynamic viral markers predict treatment response in hepatitis B
Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in…
Combination strategy may optimize interferon-based therapy for chronic hepatitis B
Background and objectives Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen…
Postpartum mothers more likely to be cured of hepatitis C with bedside treatment
Hepatitis C, a bloodborne virus that damages the liver, can cause cirrhosis, liver cancer, liver failure and death…